1. Pink Sheet
  2. >>R&D

Clinical Trials In China: As US Lawmakers Consider Crackdown, Here Are The Implications

 
• By Sarah Karlin-Smith

If the US Congress continues to target trials at Chinese military hospitals, the impact could be relatively small, while a broader focus could upend multinational development programs. 

map of China
Some US lawmakers want to crack down on clinical trials conducted in China. • Source: Shutterstock

A bipartisan group of US lawmakers’ concerns about clinical trials conducted at Chinese military hospitals likely would have a minimal impact on late-stage drug development if the attention translated to legislation cracking down on the US Food and Drug Administration’s ability to review applications with that data.

Key Takeaways

  • Only about 1% to 4% of the sites currently qualified and conducting Phase III research in China are military hospitals.

Lawmakers recently raised concerns about US pharma company collaborations with the hospitals. (Also see "Beyond BIOSECURE: Lawmakers Flag US...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Clinical Trials

More from R&D